HCPCS Level II
J9390
Injection, vinorelbine tartrate, 10 mg
Codes near J9390
These sit next to J9390 in the CMS Level II file. All J codes
- J9371Injection, vincristine sulfate liposome, 1 mg
- J9376Injection, pozelimab-bbfg, 1 mg
- J9380Injection, teclistamab-cqyv, 0.5 mg
- J9381Injection, teplizumab-mzwv, 5 mcg
- J9382Injection, zenocutuzumab-zbco, 1 mg
- J9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
- J9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
- J9395Injection, fulvestrant, 25 mg
- J9400Injection, ziv-aflibercept, 1 mg
- J9600Injection, porfimer sodium, 75 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 25021-0204-01 | Vinorelbine Tartrate | Sagent Pharmaceuticals | 1 |
| 25021-0204-05 | Vinorelbine Tartrate | Sagent Pharmaceuticals | 5 |
| 45963-0607-55 | Vinorelbine Tartrate | Actavis Pharma, Inc. | 1 |
| 45963-0607-56 | Vinorelbine Tartrate | Actavis Pharma, Inc. | 5 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.